|
Study group
| | | | |
%HBsAg prevalence (range)
| | |
|---|
|
Category
|
no.studies
|
N
|
n
|
Region*
|
Weighted mean all data
|
Weighted mean published data
|
Pvalue
|
References
|
|---|
|
Blood donors
|
13
|
658662
|
16788
|
A
|
2.53 (1.10, 8.70)
|
2.33 (1.70, 2.75)
|
0.51
|
[34–40] (i-n)
|
| |
16
|
223949
|
6389
|
B
|
2.68 (1.70, 4.22)
|
3.44 (2.60, 4.20)
|
0.14
|
[41–46] (o-x)
|
| |
4
|
149918
|
6675
|
C
|
4.25 (1.70, 4.90)
|
4.45 (2.92, 4.90)
|
0.50
|
[47–49] (y)
|
|
Hospital†
|
5
|
37497
|
2977
|
A
|
3.40 (1.30, 13.80)
|
1.30 (0.90, 1.63)
|
0.40
|
[50] (z-cc)
|
| |
6
|
100343
|
7781
|
B
|
7.15 (2.90, 13.60)
|
5.73 (2.90, 13.60)
|
1.00
|
[51, 52] (dd-gg)
|
| |
2
|
28392
|
6037
|
C
|
-
|
10.88 (9.60, 21.30)
|
-
|
[53, 54]
|
- Abbreviations: N number of subjects, n number of cases
-
P value calculated by the two-sided Mann-Whitney test (difference in prevalence of all data and only published data)
- * Region A: Marmara and Aegean, B: Black Sea, Central Anatolia and Mediterranean, C: Eastern and South-eastern
- † Studies based in hospital settings on non-liver-related conditions
